FMW Media’s New To The Street / Newsmax TV announces this weeks’,
Sunday, June 20, 2021, broadcasting line-up of its national
syndicated 1-hour show, 10-11AM ET.
“New to The Street’s” TV Sunday show features
8-interviews of the following Companies and their businesses
representatives:
1). Tonix Pharmaceuticals, Inc.’s (NASDAQ: TNXP)
interview with Mr. Seth Lederman, CEO
2). GreenBox POS’ (NASDAQ: GBOX) interview with
Mr. Ben Erez, CEO.
3). Global Cannabis Application Corp.’s (OTCPINK:
FUAPF) interviews with Mr. Brad Moore, CEO and Brian Collins from
Abbey Technologies, Inc.
4). Winners Inc.’s (OTCPINK: WNRS) interview
with Mr. Wayne Allyn Root, CEO
5) Gaensel Energy Group, Inc.’s (OTCPINK: GEGR)
interview with Ms. Maria Bomboi, President.
6). Cryptocurrency – MahaDAO’s ($MAHA) interview
with Mr. Steven Enamakil CEO/CTO.
7). Grapefruit USA, Inc.’s interview (OTCQB: GPFT)
with Mr. Bradley Yourist, CEO
8) Innerscope Hearing Technologies, Inc.’s
(OTCPINK: INND) interview with Mr. Matthew Moore, CEO
Tonix Pharmaceuticals, Inc.’s (NASDAQ: TNXP) CEO,
Seth Lederman, talks to “New To The Street” TV about their
Company’s pharmaceutical products, and his further discussion about
their development and FDA phase 3 on its Fibromyalgia drug. Mr.
Lederman talks about the importance of ‘HOW’ this Fibromyalgia drug
helps patients sleep better without pain.
“New to The Street” welcomes back to the show, Mr.
Ben Erez, CEO, GreenBox POS (NASDAQ: GRBX). Mr. Erez, again,
provides information to viewers about their business and their
plans to grow the Company. He provides in-depth discussion of the
Company’s successful proprietary blockchain security to build
customized payment solutions which reduce fraud and improves
processing of payments.
Brad Moore, CEO of Global Cannabis Application
Corp. (OTCPINK: FUAPF), interviews with “New To The Street” who
talks about the Company’s unique and innovated products and
solutions for medical cannabis industry. Mr. Brian Collins joins in
on the discussion, explaining the relationship and synergy between
his company, Abbey Technology, Inc. and Global Cannabis Application
Corp.
The show interviews Mr. Wayne Allyn Root, CEO of
Winners, Inc.’s (OTCPINK: WNRS) subsidiary, VegasWINNERS, Inc.
Appearing monthly on “New to The Street, Wayne talks about sports
betting, giving advice, and sharing content from VegasWINNER,
Inc.’s newly launched show, KRUSH House.
Gaensel Energy Group, Inc.’s (OTCPINK: GEGR)
President, Ms. Maria Bomboi, explains in her interview on “New to
The Street” the importance of GEGR’s comprehensive finance
modeling, as it pertains to growth companies positioned in the
global market place.
Another interview with Mr. Steven Enamakil,
CEO/CTO of MahaDAO ($MAHA), who walks our audiences through the
evolution and development of both the $MAHA token and the symbiotic
relationship with ARTH ($ARTH) Coin. Mr. Enamaki gives clear
discussion about the governance of the $MAHA token which empowers
token holders to vote on saving rate, stability fees, direction,
strategy and the future course of action for the complete
decentralized $ARTH coin.
Mr. Bradley Yourist, CEO, Grapefruit USA, Inc.
(OTCQB: GPFT) talks to “New To The Street” about their Company’s
permits, patents, licenses, manufacturing, laboratory, and
distribution of cannabis products and their Hourglass brand.
Again, Matthew Moore, CEO of InnerScope Hearing
Technologies, Inc.’s (OTCPINK: INND) joins the show, and he
continues to inform “New to The Street viewers about the Company’s
emerging and disruptive leadership in the “Direct-to-Consumer
Hearing Technology” space. And, a further discussion about their
recently launch of the Self-Adjusting Hearing Aids app.
Tonix Pharmaceuticals Holding
Corp. (NASDAQ: TNXP):
Tonix is a clinical-stage biopharmaceutical
company focused on discovering, licensing, acquiring and developing
small molecules and biologics to treat and prevent human disease
and alleviate suffering. Tonix's portfolio is primarily composed of
the central nervous system (CNS) and immunology product candidates.
The CNS portfolio includes both small molecules and biologics to
treat pain, neurologic, psychiatric and addiction conditions.
Tonix's lead CNS candidate, TNX-102 SL1, is in mid-Phase 3
development for the management of fibromyalgia, and positive data
on the RELIEF Phase 3 trial were recently reported. The Company
expects interim data from a second Phase 3 study, RALLY, in the
third quarter of 20212 and topline data in the fourth quarter
of 2021. The immunology portfolio includes vaccines to prevent
infectious diseases and biologics to address immunosuppression,
cancer, and autoimmune diseases. Tonix's lead vaccine candidate,
TNX-18003, is a live replicating vaccine based on the horsebox
viral vector platform to protect against COVID-19, primarily by
eliciting a T cell response. Tonix reported positive efficacy data
from animal studies of TNX-1800 in the first quarter of 2021.
TNX-8013, live horsepox virus vaccine for percutaneous
administration, is in development to protect against smallpox and
monkeypox – www.tonixpharma.com.
1TNX-102 SL is an investigational new drug and has
not been approved for any indication. 2Pending agreement from FDA
on statistical analysis plan
About GreenBox POS ( NASDAQ:
GRBX):
GreenBox POS (NASDAQ: GRBX) is a groundbreaking
technology company that builds customized payment solutions for a
variety of industries. GreenBox develops individual disruptive
applications integrated into an end-to-end suite of financial
products, supporting a multitude of industries with an emphasis on
Blockchain secured ledger technology. The main business focus is in
blockchain ledgering services, capable of handling large commercial
processing volumes for its merchant clients in a myriad of business
verticals. GreenBox is now capable of managing both legacy currency
transactions as well as crypto payouts. GreenBox's main operating
geography remains the USA, with additional capacity, clientele, and
technology availability developing in other countries. For more
information, visit the Company's website
at https://www.greenboxpos.com/.
About Global Cannabis Applications
Corp. (OTCPINK: FUAPF):
Global Cannabis Applications Corp. (OTCPINK:FUAPF)
is a global leader in designing, developing, SaaS licensing, and
acquiring innovative data technologies for the medical cannabis
industry. The Citizen Green and Efixii platforms are the world's
first end-to-end - from patient to regulator - medical cannabis
data solutions. They use six core technologies: mobile
applications, artificial intelligence, RegTech, smart databases,
Ethereum blockchain and GCAC smart rewards. These technologies
transparently disclose cannabis chain-of-custody events, thereby
enabling patients to provide crowd-sourced medical cannabis
efficacy data. Driven by digital and cannabis industry experts,
GCAC is focused on generating revenue from SaaS licensing its
technology, and acquiring high-quality cannabis datasets that
improve patient outcomes and become the world's largest cannabis
efficacy data provider- https://cannappscorp.com.
About WINNERS, INC. (OTCPINK:
WNRS): Winners, Inc. (OTCPINK: WNRS) through its
subsidiary VegasWINNERS, Inc., is engaged in the business of sports
gambling research, data, advice, analysis and predictions utilizing
all available media, advertising formats and its database of users.
Revenues are expected to accelerate due to the explosion of sports
handicapping arising from the 2018 Supreme Court decision that
States have the right to approve sports gambling and the resulting
State by State rapid approval of sports gambling. For more
information, please visit Winners, Inc. website at
https://vegaswinners.com/ and on social media at
https://twitter.com/vegaswinnersinc.
About Gaensel Energy Group, Inc.
(OTCPINK: GEGR):
Gaensel Energy Group, Inc. (OTCPINK: GEGR) is an
international finance and holding company which combines the
cumulative and collective knowledge of its management team. Our
management team consists of experienced professionals in Europe,
Asia, North and Latin America with proven success. Our team
has the accounting, legal and management organization with
structural skill sets to effectively evaluate and make prompt
business decisions and the resource network to facilitate high
level transactions - https://gegrgroup.com/.
About MahaDAO
($MAHA)
MahaDAO is the DeFi project behind
algorithmic valuecoin ARTH. The valuecoin gives holders' financial
freedom with zero volatility, as it is value-stable and controlled
by its community via a separate governance token, with holders able
to vote on savings rates, stability fees, direction, strategy and
future developments for the ARTH token - https://mahadao.com/.
About Grapefruit USA, Inc.
(OTCQB:GPFT)
Grapefruit is a fully licensed premier cannabis
manufacturer and distributor in the California legal cannabis
marketplace with its own branded product lines. Grapefruit’s
corporate offices are located in Westwood, Los Angeles, California.
Grapefruit is managed by a team of experts who possess the
experience, skills and resources required to succeed in the
competitive cannabis marketplace. Grapefruit delivers truly
disruptive Patented cannabis and hemp-derived products that have
fundamentally changed the way individuals use THC, CBDs, and
Hemp-derived CBDs capitalizing on the rise in demand for these
unique products. Our patented Hourglass™ topical creams
have solved the inherent difficulties of efficient skin absorption
of THC and Cannabinoids, such as CBD, CBN, CBG, and CBC as well as
Hemp-derived CBDs and cannabinoids. The architecture of
Hourglass™ cream gives us the ability to formulate endless
variations of our topical delivery cream to tailor to the specific
needs of our clientele. We have harnessed cutting edge
science and technology to bring patented; truly disruptive products
to the medicinal and recreational marketplace -
https://grapefruitblvd.com/.
About InnerScope Hearing Technologies,
Inc. (OTCPINK: INND):
InnerScope Hearing Technologies, Inc. is a
manufacturer, distributor, and retailer of FDA-Registered
Direct-to-Consumer ("DTC") App-Controlled Self-Adjusting Hearing
Aids, App-Controlled Self-Adjusting Personal Sound Amplifiers
Products, Doctor-Formulated Dietary Hearing & Tinnitus
Supplements, and Assorted Ear & Hearing Health-Related Products
with its mission is to improve the quality of life of the 70
million people in North America who suffer from hearing impairment
and/or hearing-related issues. InnerScope with its Affordable
App-Controlled Self-Adjusting Hearing Technology, combined with its
innovative point of sale Hearing Screening Kiosks designed for
consumers with mild-to-moderate hearing loss to purchase
over-the-counter hearing aids without being seen by a hearing care
professional- www.innd.com and www.NoHassleHearing.com.
About FMW Media:
FMW Media operates one of the longest-running U.S
and International sponsored and Syndicated Nielsen Rated
programming T.V. brands "New to the Street," and its blockchain
show "Exploring The Block." Since 2009, these brands run
biographical interview segment shows across major U.S. Television
networks. The TV platforms reach over 540 million homes both in the
US and international markets. FMW recently added Newsmax to its
broadcasting platform with its first show broadcasted Sunday,
December 27th. The NEWSMAX New to The Street show is syndicated on
Sundays at 10 AM EST. FMW is also one of the nation's largest
buyers of linear Television long and short form -
https://www.newsmaxtv.com/Shows/New-to-the-Street
https://www.newtothestreet.com/.
Forward-Looking Statements
Disclaimer: This press release contains forward-looking
statements within the meaning of Section 27A of the Securities Act
of 1933, as amended, and Section 21E of the Securities Exchange Act
of 1934, as amended. In some cases, you can identify
forward-looking statements by the following words: "anticipate,"
"believe," "continue," "could," "estimate," "expect," "intend,"
"may," "ongoing," "plan," "potential," "predict," "project,"
"should," "will," "would," or the negative of these terms or other
comparable terminology, although not all forward-looking statements
contain these words. Forward-looking statements are not a guarantee
of future performance or results, and will not necessarily be
accurate indications of the times at, or by, which such performance
or results achieved. This press release should be considered in
light of all filings of the Company contained in the Edgar Archives
of the Securities and Exchange Commission at www.sec.gov.
FMW Media Contact: Bryan Johnson +1 (631) 766-7462
Bryan@NewToTheStreet.com
And
“New to The Street” Business Development office
Support@NewtoTheStreet.com 1-516-696-5900
Tonix Pharmaceuticals (NASDAQ:TNXP)
Historical Stock Chart
From Mar 2024 to Apr 2024
Tonix Pharmaceuticals (NASDAQ:TNXP)
Historical Stock Chart
From Apr 2023 to Apr 2024